Among 448 melanoma samples profiled for NLRC5 mutation, missense mutations were found in 32 samples (7.1%), truncating in 6 samples (1.3%), splice in 2 samples (0.4%), and multiple in 3 samples (0.7%) (Figures 5A,B). This evidence concerns the gene NLRC5 and melanoma.